Synovium-Derived Mesenchymal Stem Cell Transplantation in Cartilage Regeneration: A PRISMA Review of in vivo Studies
- PMID: 31803726
- PMCID: PMC6873960
- DOI: 10.3389/fbioe.2019.00314
Synovium-Derived Mesenchymal Stem Cell Transplantation in Cartilage Regeneration: A PRISMA Review of in vivo Studies
Abstract
Articular cartilage damaged through trauma or disease has a limited ability to repair. Untreated, focal lesions progress to generalized changes including osteoarthritis. Musculoskeletal disorders including osteoarthritis are the most significant contributor to disability globally. There is increasing interest in the use of mesenchymal stem cells (MSCs) for the treatment of focal chondral lesions. There is some evidence to suggest that the tissue type from which MSCs are harvested play a role in determining their ability to regenerate cartilage in vitro and in vivo. In humans, MSCs derived from synovial tissue may have superior chondrogenic potential. We carried out a systematic literature review on the effectiveness of synovium-derived MSCs (sMSCs) in cartilage regeneration in in vivo studies in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocol. Twenty studies were included in our review; four examined the use of human sMSCs and 16 were conducted using sMSCs harvested from animals. Most studies reported successful cartilage repair with sMSC transplantation despite the variability of animals, cell harvesting techniques, methods of delivery, and outcome measures. We conclude that sMSC transplantation holds promise as a treatment option for focal cartilage defects. We believe that defining the cell population being used, establishing standardized methods for MSC delivery, and the use of objective outcome measures should enable future high quality studies such as randomized controlled clinical trials to provide the evidence needed to manage chondral lesions optimally.
Keywords: cartilage repair; mesenchymal stem cells; osteoarthritis; synovium; transplantation.
Copyright © 2019 To, Zhang, Romain, Mak and Khan.
Figures
Similar articles
-
Use of human induced pluripotent stem cells for cartilage regeneration in vitro and within chondral defect models of knee joint cartilage in vivo: a Preferred Reporting Items for Systematic Reviews and Meta-Analyses systematic literature review.Cytotherapy. 2021 Aug;23(8):647-661. doi: 10.1016/j.jcyt.2021.03.008. Epub 2021 May 29. Cytotherapy. 2021. PMID: 34059422 Review.
-
Platelet-Derived Microparticles Mediate the Intra-Articular Homing of Mesenchymal Stem Cells in Early-Stage Cartilage Lesions.Stem Cells Dev. 2020 Apr 1;29(7):414-424. doi: 10.1089/scd.2019.0137. Epub 2020 Mar 12. Stem Cells Dev. 2020. PMID: 32000580
-
Regenerative Potential of Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis and Chondral Defects: A Systematic Review and Meta-analysis.Arthroscopy. 2021 Jan;37(1):362-378. doi: 10.1016/j.arthro.2020.05.037. Epub 2020 Jun 1. Arthroscopy. 2021. PMID: 32497658
-
The Potential for Synovium-derived Stem Cells in Cartilage Repair.Curr Stem Cell Res Ther. 2018 Feb 23;13(3):174-184. doi: 10.2174/1574888X12666171002111026. Curr Stem Cell Res Ther. 2018. PMID: 28969580 Review.
-
Cartilage regeneration using arthroscopic flushing fluid-derived mesenchymal stem cells encapsulated in a one-step rapid cross-linked hydrogel.Acta Biomater. 2018 Oct 1;79:202-215. doi: 10.1016/j.actbio.2018.08.029. Epub 2018 Aug 28. Acta Biomater. 2018. PMID: 30165202 Free PMC article.
Cited by
-
Mesenchymal Stem Cells in Soft Tissue Regenerative Medicine: A Comprehensive Review.Medicina (Kaunas). 2023 Aug 10;59(8):1449. doi: 10.3390/medicina59081449. Medicina (Kaunas). 2023. PMID: 37629738 Free PMC article. Review.
-
Mesenchymal Stem Cell-Derived Exosomes as New Remedy for the Treatment of Neurocognitive Disorders.Int J Mol Sci. 2021 Feb 1;22(3):1433. doi: 10.3390/ijms22031433. Int J Mol Sci. 2021. PMID: 33535376 Free PMC article. Review.
-
Synovium-Derived and Bone-Derived Mesenchymal Stem/Stromal Cells from Early OA Patients Show Comparable In Vitro Properties to Those of Non-OA Patients.Cells. 2024 Jul 23;13(15):1238. doi: 10.3390/cells13151238. Cells. 2024. PMID: 39120270 Free PMC article.
-
In situ fabrication of an anisotropic double-layer hydrogel as a bio-scaffold for repairing articular cartilage and subchondral bone injuries.RSC Adv. 2023 Nov 30;13(50):34958-34971. doi: 10.1039/d3ra06222h. eCollection 2023 Nov 30. RSC Adv. 2023. PMID: 38046634 Free PMC article.
-
Infrapatellar Fat Pad/Synovium Complex in Early-Stage Knee Osteoarthritis: Potential New Target and Source of Therapeutic Mesenchymal Stem/Stromal Cells.Front Bioeng Biotechnol. 2020 Jul 28;8:860. doi: 10.3389/fbioe.2020.00860. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32850724 Free PMC article. Review.
References
-
- Akiyama H., Chaboissier M.-C., Martin J. F., Schedl A., de Crombrugghe B. (2002). The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 16, 2813–2828. 10.1101/gad.1017802 - DOI - PMC - PubMed
-
- Ando W., Tateishi K., Hart D. A., Katakai D., Tanaka Y., Nakata K., et al. . (2007). Cartilage repair using an in vitro generated scaffold-free tissue-engineered construct derived from porcine synovial mesenchymal stem cells. Biomaterials 28, 5462–5470. 10.1016/j.biomaterials.2007.08.030 - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources